A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria

Murungi LM., Kamuyu G., Lowe B., Bejon P., Theisen M., Kinyanjui SM., Marsh K., Osier FHA.

DOI

10.1016/j.vaccine.2013.06.042

Type

Journal article

Journal

Vaccine

Publisher

Elsevier BV

Publication Date

08/2013

Volume

31

Pages

3936 - 3942

Permalink Original publication